Email updates

Keep up to date with the latest news and content from Breast Cancer Research and BioMed Central.

This article is part of the supplement: Breast cancer research: the past and the future

Poster Presentation

Effect of intermittent versus chronic energy restriction on breast cancer risk biomarkers in premenopausal women: a randomised pilot trial

M Harvie1, M Chapman1, J Cuzick2, A Flyvbjerg3, P Hopwood1, S Jebb4, G Parfitt5 and A Howell1

Author Affiliations

1 CRUK Department of Medical Oncology, The University of Manchester, Manchester, UK

2 CRUK Department of Epidemiology and Statistics, Wolfson Institute, London, UK

3 Medical Research Laboratories, Aarhus University, Denmark

4 MRC Human Nutrition Research Group, Cambridge, UK

5 School of Sport and Health Science, University of Exeter, UK

For all author emails, please log on.

Breast Cancer Research 2006, 8(Suppl 2):P29  doi:10.1186/bcr1584


The electronic version of this article is the complete one and can be found online at:


Published:1 November 2006

© 2006 BioMed Central Ltd

Background

Postmenopausal breast cancer risk increases twofold in women who gain significant amounts of weight [1] and there is evidence that energy restriction may reduce risk [2]. Animal studies indicate that intermittent energy restriction (IER) reduces risk and may be superior to continuous energy restriction (CER) [3]. We have shown chronic energy restriction reduces biomarkers of breast cancer in women at risk but is hard to maintain. We hypothesise that IER may be superior to CER in reducing biomarkers of breast cancer risk and may also be more acceptable to women.

Methods

We are undertaking a 6-month randomised trial to compare the two approaches in 104 premenopausal women aged 30–45 years at high risk of breast cancer because of adult weight gain >7 kg. Women will be randomly assigned to either CER (75% estimated energy requirements: ~1,500 kcal 7 days/week) or IER (75% estimated energy requirements: 650 kcal for 2 days and ~1,800 kcal 5 days/week) over 6 months. Study end points will be measures of insulin sensitivity (HOMA, SHBG and testosterone), potential breast cancer growth factors (IGF axis, leptin and adiponectin), inflammatory markers (C-reactive protein and sialic acid), oxidative stress marker (urinary F2 isoprostane), weight and body composition (waist/hip circumference, fat free and total fat mass). The relative acceptability of IER and CER will be assessed using a quality of life questionnaire (RAND SF-36) and scales of behaviour change and adherence. The relative efficacy and acceptance of intermittent and chronic calorie restriction will inform future weight loss programmes to prevent breast cancer. Thirty-seven women have currently been recruited to the study (18 CER and 19 IER) and recruitment is planned to be completed by December 2006.

Acknowledgements

This study is funded by the Breast Cancer Campaign, the World Cancer Research Fund and Genesis.

References

  1. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC: Dual effects of weight and weight gain on breast cancer risk.

    JAMA 1997, 278:1407-1411. PubMed Abstract | Publisher Full Text OpenURL

  2. Harvie M, Howell A, Vierkant RA, Kumar N, Cerhan JR, Kelemen LE, Folsom AR, Sellers TA: Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study.

    Cancer Epidemiol Biomarkers Prev 2005, 14:656-661. PubMed Abstract | Publisher Full Text OpenURL

  3. Cleary MP, Jacobson MK, Phillips FC, Getzin SC, Grande JP, Maihle NJ: Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-alpha female mice.

    Cancer Epidemiol Biomarkers Prev 2002, 11:836-843. PubMed Abstract | Publisher Full Text OpenURL